One of the discoveries that fundamentally distinguished the emerging field of quantum physics from classical physics was the ...
Ocugen, Inc. gene therapy outlook: key 2026 catalysts, Phase 2/3 eye-disease data, BLA plans to 2028, and risks. Click for ...
With the transmission line now up and running, it’s time to ask: Just how much extra juice will New England get?
Maze Therapeutics uses its Compass genetics platform to advance kidney and obesity drugs, with MZE829 Phase 2 data due in ...
The move enshrines funding for the microtransit service, extending the contract for its operations and readying it as part of its transit offerings. The Metropolitan Transit Authority of Harris County ...